Development of highly sensitive cell-based AKT kinase ELISA for monitoring PI3K beta activity and compound efficacy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development of highly sensitive cell-based AKT kinase ELISA for monitoring PI3K beta activity and compound efficacy

Published:2017-11-02 Issue:6 Volume:38 Page:663-674
ISSN:1532-1819
Container-title:Journal of Immunoassay and Immunochemistry
language:en
Short-container-title:Journal of Immunoassay and Immunochemistry

Author:

Yanamandra Mahesh¹,Kole Labanyamoy²,Giri Archana³,Mitra Sayan¹

Affiliation:

1. Department of In-vitro Biology, GVK Biosciences Private Limited, Hyderabad

2. Head R&D at Premas Biotech – ‎Premas Biotech, Gurgaon, India

3. Centre for Biotechnology, Institute of Science and Technology, Jawaharlal Nehru Technological University, Hyderabad, India

Publisher

Informa UK Limited

Subject

Medical Laboratory Technology,Clinical Biochemistry,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/15321819.2017.1385027

Reference23 articles.

1. PI3K and cancer: lessons, challenges and opportunities

2. Structural Basis for Activation and Inhibition of Class I Phosphoinositide 3-Kinases

3. PI3K/AKT signaling pathway and cancer: an updated review

4. Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery

5. Targeting the PI3K/mTOR Pathway in Pediatric Hematologic Malignancies

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rosemary officinalis extract mitigates potassium dichromate-induced testicular degeneration in male rats: Insights from the Nrf2 and its target genes signaling pathway;Toxicology Reports;2024-12

2. A study on molecular mechanism of Xihuang pill in the treatment of glioblastoma based on network pharmacology and validation in vitro and in vivo;Journal of Ethnopharmacology;2024-04

3. Guggulsterone from Commiphora mukul potentiates anti-glioblastoma efficacy of temozolomide in vitro and in vivo via down-regulating EGFR/PI3K/Akt signaling and NF-κB activation;Journal of Ethnopharmacology;2023-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3